Scrotal Cancer Incidence Rises in New Study
A new analysis tracks a 5.2% annual increase in cases and identifies predictors of survival for this rare condition.
Updated on Oct. 27, 2026 in Cancer
Live Poll
Does the rise in specific cancer rates make you more likely to seek early preventive screenings?
A new retrospective cohort study reports that the incidence of scrotal squamous cell carcinoma rose by 5.2% annually between 2000 and 2023. This rare cancer, which carries a 93% two-year survival rate, was analyzed using data from over 1,000 patients in the United States.
Why it matters
Understanding incidence trends and survival predictors helps patients and clinicians recognize the importance of early detection and risk factors for this rare condition. Identifying predictors like age, tumor size, and social status may improve future screening and treatment discussions.
This retrospective study utilized SEER-17 data to analyze 1,015 patients diagnosed between 2000 and 2023, reporting an age-adjusted incidence of 0.50 per million person-years. Researchers noted a 93% two-year disease-specific survival rate, though variables such as age, tumor size, and marital status influenced outcomes.
The players
SEER-17
The Surveillance, Epidemiology, and End Results program, which provides cancer statistics from designated geographic areas in the United States.
The details
Scrotal squamous cell carcinoma (SCC) originates from the skin cells of the scrotum, with this study finding that nearly 60% of identified cases were invasive rather than in situ. Survival predictors identified by the researchers included age over 60, tumor sizes exceeding 25 mm, and unmarried status. While the study observed rising incidence rates, authors project that wider HPV vaccination coverage could lead to lower rates of genital squamous cell carcinomas in the coming years.
Timeline
The retrospective study analyzed patient data collected from 2000 to 2023.
Findings from the study were published online on October 24, 2026.
Health Landscape
This research utilizes the SEER-17 database to provide a longitudinal perspective on a rare cancer, extending established population health tracking efforts. It contributes to the broader medical understanding of rare urologic malignancies within the current oncological literature.
Readers should be aware that skin changes in the genital area warrant a conversation with a primary care physician or dermatologist. Those over 60 or with a history of suspicious skin lesions may find it particularly useful to discuss screening and monitoring strategies with their doctor.
The takeaway
While scrotal squamous cell carcinoma remains rare, the observed upward trend in incidence highlights the importance of monitoring for new or changing skin lesions. Any persistent skin abnormalities should be reviewed during your next wellness visit with a qualified healthcare provider.
Further reading
For more information on trends in malignancy, visit the Cancer section.
Source note: This article includes information reported by Medscape.
Live Poll
Does the rise in specific cancer rates make you more likely to seek early preventive screenings?
